Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

N Engl J Med. 2004 Aug 5;351(6):585-92. doi: 10.1056/NEJMra035279.
No abstract available

Publication types

  • Review

MeSH terms

  • Aldosterone / blood
  • Aldosterone / metabolism
  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Humans
  • Hyperkalemia / chemically induced*
  • Hyperkalemia / prevention & control
  • Hyperkalemia / therapy*
  • Kidney / metabolism
  • Potassium / metabolism
  • Renin-Angiotensin System / drug effects*
  • Renin-Angiotensin System / physiology
  • Risk Factors
  • Sodium / metabolism

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Aldosterone
  • Sodium
  • Potassium